The use of interconnected β-tricalcium phosphate as bone substitute after curettage of benign bone tumours

Objective The purpose of this study was to analyse the clinical and radiological outcome in patients after implantation of β-tricalcium phosphate as a bone graft substitute to fill the defects after curettage of benign bone tumours and tumour-like lesions.